This invention is related to novel carboxyl substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
本发明涉及一种新型的羧基取代的色苷衍生物,可用于治疗β-3受体介导的疾病。
CARBOXYL SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA 3 ADRENORECEPTOR AGONISTS
申请人:Bayer Corporation
公开号:EP1040106B1
公开(公告)日:2002-08-28
US6469031B1
申请人:——
公开号:US6469031B1
公开(公告)日:2002-10-22
US6797714B2
申请人:——
公开号:US6797714B2
公开(公告)日:2004-09-28
[EN] CARBOXYL SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA 3 ADRENORECEPTOR AGONISTS<br/>[FR] DERIVES DE CHROMANNE A SUBSTITUTION CARBOXYLE, UTILES COMME AGONISTES DE L'ADRENORECEPTEUR BETA-3
申请人:BAYER CORPORATION
公开号:WO1999032476A1
公开(公告)日:1999-07-01
(EN) This invention is related to novel carboxyl substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.(FR) Cette invention se rapporte à de nouveaux dérivés de chromanne à substitution carboxyle, qui sont utiles dans le traitement des états induits par le récepteur bêta-3.